Apoe genotype disclosure

1 paper3 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Funders: National Center for Advancing Translational Sciences and 1 more

Human trial1

Outcomes

Adverse events

no changein humans1

1 study

Apoe genotype disclosure has no effect on adverse events in humans (N = 2 vs N = 3).
Human trial15 months69% womens
Psychological impacts of APOE genotype disclosure among Latinos in New York City: a randomized controlled trial
Alzheimer's & dementia : the journal of the Alzheimer's Association1 Sep 2026

IES-R

no changein humans1

1 study

Apoe genotype disclosure has no effect on IES-R in humans (MD 0.00, p = 0.98 at 6 weeks).
Human trial15 months69% womens
Psychological impacts of APOE genotype disclosure among Latinos in New York City: a randomized controlled trial
Alzheimer's & dementia : the journal of the Alzheimer's Association1 Sep 2026

Latest

1 in 12 months

Alzheimer's & Dementia9 Sep

Psychological impacts of APOE genotype disclosure among Latinos in New York City: a randomized controlled trial

Randomised trial in peopleInterventions

Paper

Apoe genotype disclosure

Outcomes

Latest

Psychological impacts of APOE genotype disclosure among Latinos in New York City: a randomized controlled trial

Related